Study Shows Ritalin, Concerta Pose Cancer Risk Factor
A study released Thursday, (February 24, 2005) links Ritalin to an increased cancer risk and other health problems. In a small but startling study, researchers found that 1 out of every 12 children using methylphenidate experienced a threefold increase in levels of chromosome abnormalities, occurrences associated with increased risks of cancer and other adverse health effects.
These chromosome abnormalities occurred after just three months of using the drug methylphenidate, the generic name for a group of amphetamines that includes Ritalin, Concerta, Metadate CD and others. Methylphenidate is the most widely prescribed of a class of drugs used to treat ADHD.
Click [here] to view the full version of this article.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment